Dolby Laboratories Inc.

NYSE: DLB · Real-Time Price · USD
77.56
-0.16 (-0.21%)
At close: May 13, 2025, 3:59 PM
77.58
0.03%
After-hours: May 13, 2025, 05:53 PM EDT

Dolby Laboratories Revenue Breakdown

Period Ending Sep 27, 2024 Sep 29, 2023 Sep 30, 2022 Sep 24, 2021 Sep 25, 2020 Sep 27, 2019
Licensing, Brodcast Revenue Revenue 409.11M 451.72M 433.99M 475.65M 439.42M 474.15M
Licensing, Brodcast Revenue Revenue Growth -9.43% +4.08% -8.76% +8.25% -7.33% n/a
Licensing, CE Revenue Revenue 165.82M 170.2M 186.28M 181.94M 152.61M 154.4M
Licensing, CE Revenue Revenue Growth -2.57% -8.64% +2.39% +19.22% -1.16% n/a
Licensing, Mobile Revenue Revenue 235.77M 243.9M 238.74M 261.23M 226.97M 193.05M
Licensing, Mobile Revenue Revenue Growth -3.33% +2.16% -8.61% +15.09% +17.57% n/a
Licensing, Other Revenue Revenue 229.8M 207.75M 154.44M 153.4M 127.28M 172.09M
Licensing, Other Revenue Revenue Growth +10.61% +34.52% +0.68% +20.52% -26.04% n/a
Licensing, PC Revenue Revenue 141.3M 124.36M 151.08M 141.92M 132.3M 113.6M
Licensing, PC Revenue Revenue Growth +13.62% -17.68% +6.45% +7.27% +16.47% n/a
Products And Services Revenue 91.93M 101.81M 89.26M 67.11M 83.22M 134.34M
Products And Services Revenue Growth -9.71% +14.06% +33.01% -19.35% -38.06% n/a
Total Licensing Revenue Revenue 1.18B 1.2B 1.16B 1.21B 1.08B 1.11B
Total Licensing Revenue Revenue Growth -1.35% +2.87% -4.09% +12.57% -2.59% n/a

Operating Expense Breakdown

Period Ending Sep 27, 2024 Jun 28, 2024 Mar 29, 2024 Dec 29, 2023 Sep 29, 2023 Jun 30, 2023 Mar 31, 2023 Dec 30, 2022 Sep 30, 2022 Jul 1, 2022 Apr 1, 2022 Dec 31, 2021 Sep 24, 2021 Jun 25, 2021 Mar 26, 2021 Dec 25, 2020 Sep 25, 2020 Jun 26, 2020 Mar 27, 2020 Dec 27, 2019 Sep 27, 2019 Jun 28, 2019 Mar 29, 2019 Dec 28, 2018 Sep 28, 2018 Jun 29, 2018 Mar 30, 2018 Dec 29, 2017 Sep 29, 2017 Jun 30, 2017 Mar 31, 2017 Dec 30, 2016 Sep 30, 2016 Jul 1, 2016 Apr 1, 2016 Jan 1, 2016 Sep 25, 2015 Jun 26, 2015 Mar 27, 2015
Selling, General, and Administrative Revenue 154.37M 146.79M 156.78M 144.17M 157.48M 155.55M 157.63M 142.18M 147.27M 144.23M 182.92M 159.61M 152.66M 136.83M 137.44M 129.9M 136.98M 121.78M 149.28M 147.65M 135.16M 137.57M 140.11M 136.41M 136.2M 127.92M 124.77M 118.43M 118.78M 117.98M 118.87M 112.72M 114.49M 116.8M 114.3M 118.53M 120.2M 116.37M 111.59M
Selling, General, and Administrative Revenue Growth +5.16% -6.37% +8.75% -8.45% +1.24% -1.32% +10.87% -3.46% +2.11% -21.15% +14.60% +4.56% +11.57% -0.45% +5.81% -5.17% +12.48% -18.43% +1.11% +9.24% -1.75% -1.81% +2.71% +0.16% +6.48% +2.52% +5.35% -0.29% +0.68% -0.75% +5.46% -1.55% -1.98% +2.19% -3.57% -1.39% +3.30% +4.28% n/a
Research and Development Revenue 68.64M 65.5M 62.49M 67.03M 70.43M 68.7M 67.95M 64.45M 62.07M 62.86M 67.42M 68.82M 61.97M 62.09M 65.81M 63.77M 61.73M 59.58M 60.09M 57.65M 60.19M 60.41M 58.63M 58.65M 60.5M 60.36M 59.49M 56.44M 57.82M 59.63M 58.34M 57.52M 59.21M 54.98M 52.09M 53.33M 50.19M 45.51M 56.6M
Research and Development Revenue Growth +4.79% +4.81% -6.77% -4.82% +2.52% +1.10% +5.43% +3.83% -1.26% -6.77% -2.04% +11.07% -0.21% -5.64% +3.19% +3.31% +3.60% -0.84% +4.23% -4.22% -0.36% +3.04% -0.04% -3.06% +0.24% +1.45% +5.40% -2.38% -3.03% +2.21% +1.43% -2.86% +7.71% +5.55% -2.33% +6.25% +10.29% -19.60% n/a